United States· US:63323-781_ef0a4c9f-a65e-48dd-b625-eb76a18905f2
Vecuronium Bromide
A vecuronium product containing vecuronium bromide, registered in United States by Fresenius Kabi USA, LLC. The same ATC class is registered in 6 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Vecuronium is registered in 6 of 19 countries.
Countries holding a registration under ATC M03AC03 (vecuronium), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 3 of them publish a price we can compare per daily dose
Vecuronium · ATC M03AC03
6 / 19 countries
- Finlandprice
- Germany
- Netherlands
- Norwayprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- Vecuronium Bromide
- Manufacturer
- Fresenius Kabi USA, LLC
- Country
- United States (US)
- ATC code
- M03AC03
- ATC class
- Vecuronium
- Defined daily dose
- 6.3 mg, P
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- June 3, 2026
Packs & prices · 1
- ndc11633237811010 VIAL in 1 CARTON (63323-781-10) / 10 mL in 1 VIAL (63323-781-21)
Regulatory notes
Interactions
125 interactions on record for vecuronium.
Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Vecuronium · interactions on record
125 records
- 12 severe
- 59 moderate
- 4 minor
- 50 info
Most severe, free to view
- NeomycinA07AA01severe
- StreptomycinA07AA04severe
- Polymyxin BA07AA05severe
- ParomomycinA07AA06severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Vecuronium in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomNorcuron 10mg powder and solvent for solution for injection vialsOrganon Pharma (UK) Ltd
- GermanyVecuronium BradexBradex S.A.
- FinlandNorcuronN.V. Organon
- NetherlandsVecuronium SUN 10 mg poeder voor oplossing voor injectie en intraveneuze infusieSun Pharmaceutical Industries Europe B.V.
- NorwayVecuronium inresaInresa Arzneimittel
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Germany · Vecuronium Bradex, Vecuronium Inresa
- United Kingdom (Northern Ireland) · Vecuronium Bromide, Vecuronium Bromide Bradex
- Greece · Vecurol
- Croatia · Veculex
- Netherlands · Vecuronium Sun
- Portugal · Brometo De Vecurónio Bradex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d0ac15d5-f94f-4673-9cd4-e1ba3ed1eb33 GET /v1/drugs/d0ac15d5-f94f-4673-9cd4-e1ba3ed1eb33?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unii": {
"unii": "7E4PHP5N1D",
"rxcui": "11153",
"inchikey": "VEPSYABRBFXYIB-PWXDFCLTSA-M",
"display_name": "VECURONIUM BROMIDE",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "INTRAVENOUS",
"spl_meta": {
"b012b1b1-9e59-4525-8f4d-dae98344d15f": {
"match": "brand_token",
"title": "VECURONIUM BROMIDE INJECTION, POWDER, FOR SOLUTION [PHLOW CORP.]",
"spl_version": "6",
"published_date": "2026-03-20"
}
},
"productid": "63323-781_ef0a4c9f-a65e-48dd-b625-eb76a18905f2",
"productndc": "63323-781",
"dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
"orange_book": {
"appl_no": "205390",
"products": [
{
"rs": false,
"rld": false,
"te_code": "AP",
"strength": "10MG/VIAL",
"product_no": "001",
"approval_date": "May 26, 2016"
},
{
"rs": false,
"rld": false,
"te_code": "AP",
"strength": "20MG/VIAL",
"product_no": "002",
"approval_date": "May 26, 2016"
}
],
"appl_type": "A"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "VECURONIUM BROMIDE",
"shortage_reason": "Vecuronium Bromide Injection",
"shortage_status": "current",
"proprietary_name": "Vecuronium Bromide",
"active_ingred_unit": "mg/mL",
"application_number": "ANDA205390",
"marketing_category": "ANDA",
"nonproprietary_name": "Vecuronium Bromide",
"start_marketing_date": "20160630",
"active_numerator_strength": "1"
}See everything about vecuronium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.